Results (3754)

PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use

Clinical Trials Information System now supports submission, assessment and oversight of all trials in the EU
The review of Vimkunya was expedited because of public health interest
EMA opinion for ivermectin and albendazole supports global efforts to eliminate widespread infections

Eight new medicines recommended for approval; one positive opinion for a medicine intended for use outside the EU

The extensive use of azole fungicides (azoles), particularly in some agricultural and horticultural practices, can increase the risk of Aspergillus fungi developing resistance to essential antifungal treatments. This significant finding is highlighted in a report by the five EU health and environment agencies, with support from the European...

Reporting of medicine shortages by marketing authorisation holders and regulators in one single platform

Agency marks milestone highlighting its changing role in Europe

25 new medicines recommended for approval; two with a new active substance

These vaccines will protect sheep and cattle from disease outbreaks of newly emerged serotype-3